DHP-B, a CPT1A inhibitor, disrupts CPT1A-VDAC1 interaction in the mitochondria, increasing mitochondrial permeability and reducing oxygen consumption and energy metabolism in CRC cells (Hu et al., 2023). The gene discussed is CPT1A; the disease is colorectal carcinoma.